Eagle Global Advisors LLC Taro Pharmaceutical Industries LTD Transaction History

Eagle Global Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$75.36 - $86.57 $489,840 - $562,705	-6,500 Closed	0 $0
Q1 2019 Apr 22, 2019	BUY	$85.97 - $108.09 $558,805 - $702,585	6,500 New	6,500 $703,000
Q4 2018 Jan 30, 2019	SELL	$78.25 - $107.92 $172,150 - $237,424	-2,200 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$97.82 - $116.09 $215,203 - $255,398	2,200 New	2,200 $216,000
Q1 2018 May 04, 2018	SELL	$95.91 - $107.26 $527,505 - $589,930	-5,500 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$97.26 - $116.2 $534,930 - $639,100	5,500	5,500 $620,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Eagle Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Eagle Global Advisors LLC with notifications on news.